## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.5% below STRENGTH zone (3.0-6.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($133.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 3)

**1. Globe Life (NYSE:GL) CEO Frank Svoboda Sells 9,379 Shares**
- Source: MarketBeat | 20251217T231026 | Neutral | Relevance: 100%
- Globe Life (NYSE:GL) CEO Frank Svoboda sold 9,379 shares of the company's stock on December 16th for over $1.3 million, reducing his stake by 20.73%. This sale comes after the company beat quarterly EPS expectations and set positive FY2025-FY2026 guidance, with analysts largely maintaining a "buy" rating and an average target price of $164.89 for GL. The stock currently trades around $138.75 and pays a quarterly dividend of $0.27.

**2. Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation**
- Source: Fox 59 | 20251216T160820 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by Globe Life Inc. (NYSE:GL) and its officers/directors. The firm is encouraging investors who purchased Globe Life securities before May 8, 2019, and still hold them, to contact them to learn more about the investigation. They represent investors on a contingency fee basis and aim to recover losses for those affected.

**3. Globe Life Inc. (NYSE:GL) Given Consensus Rating of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20251216T090817 | Bullish | Relevance: 100%
- Eleven research firms have collectively given Globe Life Inc. (NYSE:GL) a "Moderate Buy" consensus rating, with nine recommending a buy and two a hold. The average twelve-month price target is set at $164.8889. The company recently reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend of $0.27 per share.

**4. Globe Life Insider Sold Shares Worth $1,317,072, According to a Recent SEC Filing**
- Source: marketscreener.com | 20251217T222824 | Somewhat-Bearish | Relevance: 100%
- An insider at Globe Life Inc. sold shares valued at $1,317,072, as disclosed in a recent SEC filing. This transaction was reported on December 17, 2025, according to MT Newswires. This follows other significant insider activities and analyst ratings adjustments for Globe Life.

**5. Is the Options Market Predicting a Spike in Globe Life Stock?**
- Source: Yahoo Finance | 20251217T150808 | Somewhat-Bearish | Relevance: 100%
- Investors should monitor Globe Life (GL) stock due to recent activity in the options market, particularly the high implied volatility of its Dec 19, 2025 $04.86 Call. High implied volatility suggests market expectations of a significant price movement, possibly driven by upcoming events, despite analysts currently rating Globe Life as a Zacks Rank #3 (Hold) with recent downward revisions to earnings estimates. This situation could present a trading opportunity, especially for experienced options traders looking to sell premium.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | TD Cowen | $199 | $182 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | TD Cowen | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($3.74M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 9.2x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (1 raises, avg +9%). Insider buying signal ($3.7M), management confidence. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 0.48 |
| 52W Range | $104.06 - $147.83 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 9.2 |
| Current P/E | 9.5 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 5.6% to 2.5% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.5pp (needs >3.0% for momentum thesis). MRS_5 (-0.7%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.79), confirming momentum. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.52% (CS: 75) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.033x | Above |
| vs SMA200 | 1.066x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.70
- **Stop Loss:** $133.82 (3.5% risk)
- **Target:** $143.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 146
- **Position Value:** $20,250.20
- **Portfolio %:** 20.25%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*